HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y M Deo Selected Research

Breast Neoplasms (Breast Cancer)

12/2003Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.
6/2000Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y M Deo Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
12/2003 - 06/2000
2Neoplasms (Cancer)
02/2001 - 06/2000
1Fever (Fevers)
12/2003
1Chills
12/2003
1Necrosis
12/2003
1Disease Progression
12/2003
1Lymphoma (Lymphomas)
02/2001

Drug/Important Bio-Agent (IBA)

1Filgrastim (Neupogen)FDA Link
12/2003
1Biological ProductsIBA
12/2003
1MDX-H210 antibodyIBA
12/2003
1Interleukin-6 (Interleukin 6)IBA
12/2003
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2003
1Immunoglobulin A (IgA)IBA
02/2001
1Immunoglobulin G (IgG)IBA
02/2001
1Fc Receptors (Fc Receptor)IBA
02/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2000
1CytokinesIBA
06/2000
1Fc(alpha) receptorIBA
06/2000
1IgG Receptors (Fc gamma RI)IBA
06/2000
1Macrophage Colony-Stimulating FactorIBA
06/2000

Therapy/Procedure

1Immunotherapy
12/2003
1Therapeutics
06/2000